Balboa Wealth Partners Gilead Sciences, Inc. Transaction History

Balboa Wealth Partners

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$71.58 - $87.29 $4,724 - $5,761	-66 Reduced 1.84%	3,514 $257,000
Q4 2023 Feb 09, 2024	SELL	$73.27 - $83.09 $19,563 - $22,185	-267 Reduced 6.94%	3,580 $290,000
Q3 2023 Oct 23, 2023	SELL	$73.94 - $80.67 $33,051 - $36,059	-447 Reduced 10.41%	3,847 $288,000
Q2 2023 Aug 08, 2023	SELL	$76.01 - $86.7 $113,026 - $128,922	-1,487 Reduced 25.72%	4,294 $330,000
Q1 2023 May 11, 2023	SELL	$77.31 - $88.08 $53,807 - $61,303	-696 Reduced 10.75%	5,781 $479,000
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $970,945 - $1.39 Million	-15,580 Reduced 70.64%	6,477 $556,000
Q3 2022 Jan 04, 2023	BUY	$59.54 - $68.01 $1.31 Million - $1.5 Million	22,057 New	22,057 $1.36 Million

1,931

991M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Balboa Wealth Partners, based on Form 13F filings with the SEC.

Stay updated on Balboa Wealth Partners with notifications on news.